|
1
|
De Potter P: Ocular manifestations of
cancer. Curr Opin Ophthalmol. 9:100–104. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shields CL, Kaliki S, Crabtree GS,
Peshtani A, Morton S, Anand RA, Coco G and Shields JA: Iris
metastasis from systemic cancer in 104 patients: The 2014 Jerry A.
Shields Lecture. Cornea. 34:42–48. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shields CL, Shields JA, Gross NE, Schwartz
GP and Lally SE: Survey of 520 eyes with uveal metastases.
Ophthalmology. 104:1265–1276. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lampaki S, Kioumis I, Pitsiou G, Lazaridis
G, Syrigos K, Trakada G, Kakolyris S, Zarogoulidis K, Mpoukovinas
I, Rapti A and Zarogoulidis P: Lung cancer and eye metastases. Med
Hypothesis Discov Innov Ophthalmol. 3:40–44. 2014.PubMed/NCBI
|
|
5
|
Su HT, Chen YM and Perng RP: Symptomatic
ocular metastases in lung cancer. Respirology. 13:303–305. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kreusel KM, Bechrakis NE, Wiegel T, Krause
L and Foerster MH: Incidence and clinical characteristics of
symptomatic choroidal metastasis from lung cancer. Acta Ophthalmol.
86:515–519. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meziani L, Cassoux N, Le Rouic LL, Gabriel
CL, Dendale R, Sastre X, Catherine D, Livartowski A, Plancher C,
Asselain B and Desjardins L: Uveal metastasis revealing lung
cancer. J Fr Ophtalmol. 35:420–425. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shah SU, Mashayekhi A, Shields CL, Walia
HS, Hubbard GB III, Zhang J and Shields JA: Uveal metastasis from
lung cancer: Clinical features, treatment, and outcome in 194
patients. Ophthalmology. 121:352–357. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hoffman PC, Mauer AM and Vokes EE: Lung
cancer. Lancet. 355:479–485. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shields JA, Shields CL, Kiratli H and de
Potter P: Metastatic tumors to the iris in 40 patients. Am J
Ophthalmol. 119:422–430. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Soysal HG: Metastatic tumors of the uvea
in 38 eyes. Can J Ophthalmol. 42:832–835. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jurecka T, Skorkovská S, Coupková H and
Postránecká V: Iris metastasis as the first sign of small-cell lung
carcinoma with metastatic involvement of the mediastinum. Klin
Onkol. 22:179–182. 2009.(In Czech). PubMed/NCBI
|
|
13
|
Straub M, Muselier A, Bron A and
Creuzot-Garcher C: An iris metastasis revealed a bronchopulmonary
cancer. J Fr Ophtalmol. 37:125–129. 2014.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ferry AP and Font RL: Carcinoma metastatic
to the eye and orbit II. A clinicopathological study of 26 patients
with carcinoma metastatic to the anterior segment of the eye. Arch
Ophthalmol. 93:472–482. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanthan GL, Jayamohan J, Yip D and Conway
RM: Management of metastatic carcinoma of the uveal tract: An
evidence-based analysis. Clin Experiment Ophthalmol. 35:553–565.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Marigo FA and Finger PT: Anterior segment
tumors: Current concepts and innovations. Surv Ophthalmol.
48:569–593. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Augustine H, Munro M, Adatia F, Webster M
and Fielden M: Treatment of ocular metastasis with anti-VEGF: A
literature review and case report. Can J Ophthalmol. 49:458–463.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dietrich CF, Ignee A, Barreiros AP,
Schreiber-Dietrich D, Sienz M, Bojunga J and Braden B:
Contrast-enhanced ultrasound for imaging of adrenal masses.
Ultraschall Med. 31:163–168. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cui XW, Hocke M, Jenssen C, Ignee A, Klein
S, Schreiber-Dietrich D and Dietrich CF: Conventional ultrasound
for lymph node evaluation, update 2013. Z Gastroenterol.
52:212–221. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sperandeo M, Sperandeo G, Varriale A,
Filabozzi P, Decuzzi M, Dimitri L and Vendemiale G:
Contrast-enhanced ultrasound (CEUS) for the study of peripheral
lung lesions: A preliminary study. Ultrasound Med Biol.
32:1467–1472. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Caremani M, Benci A, Lapini L, Tacconi D,
Caremani A, Ciccotosto C and Magnolfi AL: Contrast enhanced
ultrasonography (CEUS) in peripheral lung lesions: A study of 60
cases. J Ultrasound. 11:89–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sartori S, Postorivo S, Vece FD, Ermili F,
Tassinari D and Tombesi P: Contrast-enhanced ultrasonography in
peripheral lung consolidations: What's its actual role? World J
Radiol. 5:372–380. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miller J: Metastatic ocular tumors of the
anterior segment. Optometry. 79:189–192. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Radcliffe NM and Finger PT: Eye cancer
related glaucoma: Current concepts. Surv Ophthalmol. 54:47–73.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Horn L, Dahlberg SE, Sandler AB, Dowlati
A, Moore DF, Murren JR and Schiller JH: Phase II study of cisplatin
plus etoposide and bevacizumab for previously untreated,
extensive-stage small-cell lung cancer: Eastern Cooperative
Oncology Group Study E3501. J Clin Oncol. 27:6006–6011. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nakashima C, Keino H, Watanabe T, Taki W
and Okada AA: Intravitreal bevacizumab for iris metastasis of
small-cell lung carcinoma with neovascular glaucoma. Jpn J
Ophthalmol. 55:80–81. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schell JC, Koenig SB, Bastin K and
Wirostko WJ: Intracameral bevacizumab administered for non-small
cell lung cancer metastasis to iris. Clin Pract. 1:e392011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yokouchi H, Kitahashi M, Oshitari T and
Yamamoto S: Intravitreal bevacizumab for iris tumor metastasized
from large cell neuroendocrine carcinoma of lung. Graefes Arch Clin
Exp Ophthalmol. 251:2243–2245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou Q, Liang J and Lu H: Intravitreal
bevacizumab for ocular metastasis of multiple myeloma. Optom Vis
Sci. 90:e236-e240, 1028. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin CJ, Li KH, Hwang JF and Chen SN: The
effect of intravitreal bevacizumab treatment on choroidal
metastasis of colon adenocarcinoma-case report. Eye (Lond).
24:1102–1103. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zako M, Takeyama M, Naito E, Mizumoto K
and Iwaki M: Choroidal and optic disc metastases from breast cancer
and their response to combination pharmacotherapy with tamoxifen,
cyclophosphamide hydrate, letrozole, and bevacizumab. J Ocul
Pharmacol Ther. 28:89–93. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Maudgil A, Sears KS, Rundle PA, Rennie IG
and Salvi SM: Failure of intravitreal bevacizumab in the treatment
of choroidal metastasis. Eye (Lond). 29:707–711. 2015.PubMed/NCBI
|
|
33
|
Fabrini MG, Genovesi-Ebert F, Perrone F,
De Liguoro M, Giovannetti C, Bogazzi F, Rizzo S, Martino E and
Cionini L: A multimodal approach to the treatment of bilateral
choroidal metastases from thyroid carcinoma. Rare Tumors. 1:e42009.
View Article : Google Scholar : PubMed/NCBI
|
